Guangxi Liuzhou Pharm Co Ltd (603368) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Guangxi Liuzhou Pharm Co Ltd (603368) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.64 Million ≈ $6.68 Million USD) by net assets (CN¥8.14 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Guangxi Liuzhou Pharm Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Guangxi Liuzhou Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Guangxi Liuzhou Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Guangxi Liuzhou Pharm Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Guangxi Liuzhou Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangxi Liuzhou Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Emperor of Cleaning Hi-Tech Co Ltd SHG:603200	0.010x
Vitec Software Group AB (publ) ST:VIT-B	0.155x
Jiangsu Asia Pacific Light Alloy Technology Co Ltd SHE:002540	-0.018x
Arena REIT AU:ARF	0.026x
Harbin Xinguang Optic Electronics SHG:688011	-0.012x
EQ Resources Ltd AU:EQR	-0.169x
Medplus Health Services Limited NSE:MEDPLUS	0.159x
Ningxia Building Materials Group Co Ltd SHG:600449	0.044x

Annual Cash Flow Conversion Efficiency for Guangxi Liuzhou Pharm Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 603368 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.94 Billion ≈ $1.16 Billion	CN¥838.51 Million ≈ $122.70 Million	0.106x	+25.55%
2023-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥594.41 Million ≈ $86.98 Million	0.084x	+5.77%
2022-12-31	CN¥6.37 Billion ≈ $931.45 Million	CN¥506.43 Million ≈ $74.11 Million	0.080x	+38.77%
2021-12-31	CN¥5.81 Billion ≈ $849.64 Million	CN¥332.88 Million ≈ $48.71 Million	0.057x	-53.04%
2020-12-31	CN¥5.44 Billion ≈ $796.71 Million	CN¥664.69 Million ≈ $97.26 Million	0.122x	+37.70%
2019-12-31	CN¥4.66 Billion ≈ $681.54 Million	CN¥412.91 Million ≈ $60.42 Million	0.089x	+1508.91%
2018-12-31	CN¥4.05 Billion ≈ $592.21 Million	CN¥22.30 Million ≈ $3.26 Million	0.006x	+105.91%
2017-12-31	CN¥3.57 Billion ≈ $522.19 Million	CN¥-332.59 Million ≈ $-48.67 Million	-0.093x	-378.42%
2016-12-31	CN¥3.24 Billion ≈ $473.78 Million	CN¥108.39 Million ≈ $15.86 Million	0.033x	+142.47%
2015-12-31	CN¥1.36 Billion ≈ $199.10 Million	CN¥-107.25 Million ≈ $-15.69 Million	-0.079x	+30.12%
2014-12-31	CN¥1.17 Billion ≈ $171.78 Million	CN¥-132.42 Million ≈ $-19.38 Million	-0.113x	-353.08%
2013-12-31	CN¥501.00 Million ≈ $73.31 Million	CN¥22.33 Million ≈ $3.27 Million	0.045x	-72.11%
2012-12-31	CN¥378.59 Million ≈ $55.40 Million	CN¥60.51 Million ≈ $8.85 Million	0.160x	-67.14%
2011-12-31	CN¥274.23 Million ≈ $40.13 Million	CN¥133.38 Million ≈ $19.52 Million	0.486x	--

About Guangxi Liuzhou Pharm Co Ltd

SHG:603368 China Medical Distribution

Market Cap

$916.62 Million

CN¥6.26 Billion CNY

Market Cap Rank

#9121 Global

#2216 in China

Share Price

CN¥15.77

Change (1 day)

+0.83%

52-Week Range

CN¥14.59 - CN¥20.31

All Time High

CN¥62.90